Waters Corp (WAT) — Analysis Summary
Waters Corp (WAT) has a market cap of $36.64B with year-over-year revenue growth of +7.0%. Net margin stands at 20.3%. The stock trades at a P/E ratio of 81.6.
Key Takeaways
- Revenue changed +7.0% year-over-year
- Net margin of 20.3%
- P/E ratio of 81.6
Compared to other companies in the LABORATORY ANALYTICAL INSTRUMENTS sector, WAT posted revenue growth of +7.0% and trades at a P/E of 81.6.
Waters Corp (WAT)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Debt/EBITDA at 7.4x — highly leveraged, potential refinancing risk
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.
Sector
LABORATORY ANALYTICAL INSTRUMENTS
Employees
7,900
Headquarters
MILFORD, MA
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.